can you take tirzepatide for only 3 months Short-Term Use: 3-Month Weight Loss Plans ✨ New Patient Weight Loss

Clinical studies have found that patients taking Mounjaro achieved an average weight loss of around 22.5% of their body weight over 72 weeks

The European Medicines Agency (EMA) has recommended updating the product information for these medicines to include NAION as a side effect, with a frequency classified as very rare. June 5, 2025 JAMA Ophtalmology study- AMD A study by the University of Toronto determined that victims using semaglutide had twice the chance of developing neovascular age-related macular degeneration (nAMD)

32 (Figures 1b,c and 2b,c)

Do women lose more weight with semaglutide

This peptide is strictly intended for laboratory research and is not approved for human use or cosmetic application

Meanwhile, clinical trials have pointed to GLP-1 agonist benefits in other indications, including chronic kidney disease, metabolic dysfunction-associated steatohepatitis (MASH), Parkinsons disease, Alzheimers, and addiction